Agomelatine is a melatonin receptor agonist (MT1 and MT2 receptors) and serotonin 5-HT2C and 5-HT2B receptor antagonist, which theoretically resynchronizes circadian rhytms of man affecting MT1, MT2 and 5-HT2C receptors of main cerebral pacemaker - nucleus suprachiasmaticus hypothalami. But do we know what exactly agomelatine could do with the circadian rhythms of man? Is this unique type of effect already sufficiently mapped?

More Michal Patarák's questions See All
Similar questions and discussions